Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
Clinical trial NCT05226117 · COMPLETED
Trial details
- NCT number
- NCT05226117
- Sponsor
- IRCCS San Raffaele
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2025-09-24
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.